Dare Bioscience, Inc. (DARE)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Foreign currency translation adjustments | - | 13,090 | ||
| Comprehensive loss | - | -4,365,217 | ||
| Sale of royalty and milestone rights, net | - | - | ||
| Other income (expense), net | 10,002 | - | ||
| Loss from operations | -3,827,800 | - | ||
| Interest income | 69,848 | - | ||
| Interest expense | 268,533 | - | ||
| Net income (loss) | -4,016,483 | -4,365,217 | ||
| Basic (in shares) | 8,871,155 | 8,759,053 | ||
| Diluted (in shares) | 8,871,155 | 8,759,053 | ||
| Income (loss) per common share - basic (in usd per share) | -0.45 | -0.5 | ||
| Income (loss) per common share - diluted (in usd per share) | -0.45 | -0.5 | ||